- CEO
- Qiu Han Deng
- Full Time Employees
- 1,361
- Sector
- Consumer durables
- Industry
- Home furnishings
- Address
- Zhengchuan Glass Industrial Park Chongqing CH China 400700
- IPO Date
- Aug 22, 2017
- Business
- ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (603976.SS) is a China-based company principally engaged in the research, development, production and sale of pharmaceutical primary packaging materials, primarily tubular glass vials, ampoules and auxiliary caps; it operates four production bases with over 2,000 employees and annual capacity exceeding 10 billion glass vials, 1 billion ampoules, 1 billion cartridges, 50 million prefilled syringes and 5 billion aluminum caps. The company offers neutral borosilicate glass tubular injection vials (2ml to 50ml), low borosilicate tubular vials and ampoules, oral liquid vials, screw-neck vials, prefilled syringes (1ml to 3ml with needle or luer lock), ready-to-use cartridges (1.5ml to 3ml), push rods and injection boosters for prefilled syringes; it also provides aluminum caps, aluminum-plastic composite caps and other medicinal closures, all compliant with YBB, ISO, EP, USP standards, ISO15378, ISO17025 and US FDA DMF certifications. Products serve biological preparations, traditional Chinese medicine, chemical medicines including water/powder injections and oral liquids, plus health care products; operations span China with exports to markets including India, United States, Brazil, Vietnam, Russia, Japan, Germany and others. Founded in 1988 and headquartered in Zhengchuan Glass Industry Park, Longfengqiao Street, Beibei District, Chongqing, China, the company listed on the Shanghai Stock Exchange main board in 2017 as the first private enterprise in the pharmaceutical glass packaging sector; it maintains partnerships with leading suppliers such as Schott, NEG, Aptar and Datwyler. Recent developments include the ignition and operation of its second medium borosilicate kiln in July 2022, expansion of neutral borosilicate glass production projects funded by capital raises, attendance at CPHI China 2024 (booth N5B10) and CPHI Shanghai 2025 to showcase aseptic packaging solutions, alongside ongoing investments in borosilicate pharmaceutical glass amid national centralized procurement driving medium borosilicate adoption.